Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable ...

Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Amgen's market standing. Stay informed and make well-considered decisions with our ...

The Airbus A340 is one of the most iconic jets ever produced by Airbus, and it is a long-range wide-body quad-engine passenger airliner that was originally developed alongside the twin-engine Airbus ...

The year 2024 was a “peak year” for antisemitism, with a 340 percent increase in total antisemitic incidents worldwide compared to 2022, according to a new report published by the World ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. An Indiana woman who weighed 340 pounds killed her 10-year-old ...

Between 3% and 5% of colorectal cancers exhibit the KRAS G12C mutation. Credit: SewCreamStudio/Shutterstock. Amgen’s LUMAKRAS (sotorasib) and Vectibix (panitumumab ...

Mercedes-AMG’s all-new GT3 car is slated to begin on-track testing this year according to the brand’s head of customer racing Stefan Wendl, who ruled out a full customer rollout until 2027 ...

The Food and Drug Administration has approved Amgen sotorasib (Lumakras) with panitumumab (Vectibix) for adult patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC), as determined by an ...

Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved LUMAKRAS® (sotorasib) in combination with Vectibix® (panitumumab) for the treatment of adult patients ...

Amgen’s Lumakras and AstraZeneca’s Calquence are both in line to expand their respective oncology reaches with new FDA approvals. Calquence, in combination with chemotherapy bendamustine and ...